Fundraising FoxCelltrio
Fremont, US · 2 known investors
Find your way into Celltrio
Sign up to see every warm intro you have to Celltrio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Celltrio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.
Founders & leadership
CD
Charlie DuncheonCEO & Cofounder
JK
Jin-Oh KimCTO & Cofounder
JB
Jeff BairdChief Operations OfficerHe has held senior executive roles across organizations ranging from startups to Fortune 500 companies, with experience in business development, product innovation, and operational leadership.
CC
Chau ChavezCFO
Board
MK
Minbeom KimBoard director
Investors · 2
Funding
SEC filings, press & company announcements$30M disclosed across 2 rounds · 2025
- $15MraisedJun 2025 · 4 sourcesSource ↗
▶$15MraisedJul 2025 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedJul 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Minbeom KimDirector
- Jin-Oh KimDirector
- Raphael KimDirector
- Charlie DuncheonExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
CellaresCellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.
Cell MicrosystemsCell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine. Its products support scientists in laboratory research and single-cell isolation and analysis.
AutomataAutomata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.
Companies working in the same space as Celltrio.
In the news
Frequently asked questions
- What does Celltrio do?
- Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.
- Who founded Celltrio?
- Celltrio was founded by Charlie Duncheon, Jin-Oh Kim, Raphael Kim.
- Who are Celltrio's investors?
- Celltrio's investors include Asia2G Capital, Premier Partners.
- How much funding has Celltrio raised?
- Celltrio has disclosed $30M raised across 2 rounds.
- Where is Celltrio headquartered?
- Celltrio is headquartered in Fremont, US.